Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases. [PDF]
Borges B +8 more
europepmc +1 more source
Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review. [PDF]
Akpa B.
europepmc +1 more source
Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier. [PDF]
Tashima T, Tournier N.
europepmc +1 more source
Case report of neuronopathic mucopolysaccharidosis type II: Early intracerebroventricular enzyme replacement therapy and hematopoietic cell transplantation with developmental outcomes up to 5 years of age. [PDF]
Ikari A, Hama A, Okuyama T.
europepmc +1 more source
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial. [PDF]
Harmatz P +16 more
europepmc +1 more source
1973. Domenico Rea a Alfa Romeo - Alfa sud
Rea, Domenico, Alfa Romeo - Alfasud
core +1 more source
Integrative genomic and single-cell framework identifies druggable targets for colorectal cancer precision therapy. [PDF]
Hong Y +7 more
europepmc +1 more source
Oral trehalose improves histological and behavior symptoms of mucopolysaccharidosis type II in iduronate 2-sulfatase deficient mice. [PDF]
Lee H +8 more
europepmc +1 more source
Efficient brain delivery and sustained retention of antibodies via dual targeting of blood-brain barrier and intra-brain proteins. [PDF]
Noguchi Y +11 more
europepmc +1 more source

